Get started

NVAX

NOVAVAX Long term countWeekly update with my long-term scenario... It looks short-term bearish, but it is the best scenario for long-term bulls according to Elliott waves! It has a gap fill in the low 20s, and then a wave (c) super cycle will start. As you see on the side there is a gap of volume below 35 and then a huge amount of volume from 10s-20s, I am not saying we will go there, but needs to be served somehow, maybe 20-25... The catalyst from the revisit of the lows maybe will be a market crash or lower covid cases and no new orders, maybe a new pill, I don't know... But I think we are not out of the woods just yet, not so easy!
NASDAQ:NVAX
by FiboSnail
Novavax - Wassup?Novavax NVAX is actually lining up pretty well... from about 240, it tanked to 40, and on Friday, it gained 11% to close the week at 57.15. This caught my attention as it cleanly broke out of trendlines, breaking out also from a bearish divergence, on BOTH the weekly and daily chart. IMHO, it appears to be in technical and fractal alignment. Weekly chart bounced off a major support two weeks ago, and the last week continued the previous week's bullish end. On the daily chart, Friday's close was the highest daily close in about 5 weeks. with a strong candle closing draws obvious bullish attention. Target 80, then 125. Support at 53 and 50.
NASDAQ:NVAXLong
by Auguraltrader
3
New update for NovavaxWeekly Update! The best time of the week is when you have a clear mind and time to check the TA. I have seen this movie a couple of times before. One was not so far ago... April 6th. Sharp move down after a breakdown of a bear flag. RSI in extreme levels marked the wave iii of wave 3. Then bear flag again, triangulation of the rsi with inside hidden bearish divergence, and another move down to complete the wave v of wave 3. Now, again the same... Sharp move down after a breakdown of a bear flag. RSI in extreme levels marked the wave iii of wave 5. Then bear flag again, triangulation of the rsi with inside hidden bearish divergence, and... waiting for another move down to complete the wave v of wave 5. Both bear flag projections coincide with the target of the Elliots waves, it does not leave room for questions... Also, volume is decreasing, as expected from Wyckoff's theory, one final? shake out is expected
NASDAQ:NVAXShort
by FiboSnail
New update for Novavax (elliot waves)Finally, the price broke down after a few attempts that failed and eventually became bull traps. It was a very complex move to navigate and many times a trader can lose patience... Now we are on the way to completing wave 5 or C (I have labeled it with both). We may see a retest of the upper wedge line which will be wave (iv) or c. There will find the 2h supply zone. To support this action, some will notice the weak bullish divergence of rsi. Imo we will see volume decreasing, as we already see some, and when eventually it diminishes, we will see a decisive test of the remaining supply into the end of wave 5. There we may see a bear trap as the bears will see a channel break down, latecomers will be trapped and fear will be all over retail investors allowing smart money to accumulate the remaining floating supply in ghost mode.
NASDAQ:NVAX
by FiboSnail
Novavax: IT'S TIME TO GONovavax Short Term - We look to Sell at 48.97 (stop at 53.42) Prices expected to stall near trend line resistance. Trading volume is increasing. The trend of lower highs is located at 55.90. Preferred trade is to sell into rallies. A break of yesterdays low would confirm bearish momentum. Our profit targets will be 22.96 and 13.90 Resistance: 50.00 / 63.00 / 100.00 Support: 41.00 / 23.12 / 15.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:NVAXShort
by Saxo
Bigger Picture NVAX Projection - UpdateUpdate from post yesterday - obviously the manufacturing news killed momentum so taking this opportunity to roll to July expiration and add some lower strikes at a discount. - Chart indicates a symmetrical triangle breakdown into support. DMI suggests accumulation, this will be the spring. - Expecting yellow path to play out as price trajectory. Forming an impulse wave that takes it right through the equilibrium point where supply = demand at the intersection of support and resistance from the triangle. - initial target around 70 but will need to give this some time to unfold. - mid term I see this going to triple digits easy (by end of 2022 - that is conservative) NVAX has done this every pandemic {pop to 300s, sell off to 40s, re-accumulate and take it back into the 100s... rinse and repeat} Sincerely, Covid-19
NASDAQ:NVAXLong
by JerryManders
Covid stocks still struggling (NVAX) Novavax Short Term - We look to Sell at 54.79 (stop at 58.88) Prices expected to stall near trend line resistance. Trading volume is increasing. The trend of lower highs is located at 55.90. We therefore, prefer to fade into the rally with a tight stop in anticipation of a move back lower. Our profit targets will be 41.78 and 38.59 Resistance: 55.90 / 63.00 / 100.00 Support: 42.20 / 23.12 / 15.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:NVAXShort
by Saxo
NVAX Wyckoff Accumulation events + Elliott waves$NVAX My memorial day homework 😁 Wyckoff Accumulation events + Elliott waves I have attached my two main theories that are happening together and we are approaching the end of it soon. For wyckoff, I am expecting a big shakeout to follow. We haven't seen yet a day that has the qualities of a spring. We have only experienced some rallies that turned back quickly to the support/supply area, which imo is a test. We need to see massive selling volume and accumulation. That is coming together with the Elliott waves count. I have an alteration of the count, but does not change anything in the final outcome. I just wanted to show the similarities with the ending diagonal. A wave C or wave 5 call it as you like, is supposed to come. Maybe this will mark the final shakeout and the end of correction.
NASDAQ:NVAX
by FiboSnail
New update for Novavax (elliot waves)My weekend analysis for $NVAX Finally, we are starting to build the long expecting and hopping final wave 5 of the primary cycle corrective wave C. It was a running flat structure, which is a rare structure, that is why it was a tricky one to understand from the beginning. I have inserted some supply and demand areas in order to understand better where we will find supports and resistances and also where the price is "magnetizing" to go. On the 2h chart, we see a shooting star candle, which is confirmed, and then the gap down. Now is building up a SHS pattern, in which the right shoulder will be the wave 2 of the wave 5. It is already at 50% retracement, which is inside the area of a wave 2 target and also inside the resent daily supply zone. I am expecting to be rejected from there, but it can always go further up and maybe close the gap from yesterday before going down again. The SHS pattern if it triggers, the target coincidences with the wave 3 fib. My target area is at 38$ to 30$.
CAPITALCOM:NVAXShort
by FiboSnail
New update for Novavax (elliot waves)I have altered my count a bit in order to find the best possible valid count. (The big picture remains the same although.) The count I see, that could explain in a simple way what is going on is the following. We haven't finished the wave 5 from the collapse of December. But we are still on the extended wave 5. On this count 38 is the bottom and if we pass it the count will be invalid. I expect a bounce from low 40s to 50s-60s and then a retest of the lows and a finish of primary wave 5.
CAPITALCOM:NVAX
by FiboSnail
2
NVAX Ready to Break? Novavax Short Term - We look to Sell at 66.01 (stop at 72.46) Trades with a bearish descending triangle formation. Trading volume is increasing. We look for losses to be extended today. A close below the key support at 68.00 is expected to lead to further selling pressure. Closed below the 20-day EMA. Our profit targets will be 40.74 and 38.59 Resistance: 68.00 / 100.00 / 120.00 Support: 50.00 / 40.0 / 30.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:NVAXShort
by Saxo
Chaos Reigns Hah... These trend lines are the accumulation of attempts to figure this thing out over the last year. Ridiculous price action but learned to leverage the volatility and play the extremes. Currently at a relative downside extreme. Also signs of Wyckoff Accumulation similar to the build up when it popped Jan 2021. Time series 1-month point forecast target is 163, NVAX price action is cyclical so these forecasts are more difficult than when there is merely trend/seasonality. Technical levels I’m looking for to the upside are 111-120, 146, 180. Catalysts are here so it’s now or never I guess and calls are relatively cheap. Not financial advice.
NASDAQ:NVAXLong
by JabezDolz
Novavax Breaking Out? Novavax - Short Term - We look to Buy at 83.80 (stop at 75.92) Price action has posted a bullish Engulfing Candle and is positive for short-term sentiment. We look for gains to be extended today. Short term oscillators have turned positive. Although the bears are in control, the stalling negative momentum indicates a turnaround is possible. Our profit targets will be 101.48 and 112.00 Resistance: 90.00 / 100.00 / 140.00 Support: 70.00 / 60.00 / 50.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:NVAXLong
by Saxo
1